La L-arginina modula el metabolismo de las células T y mejora la supervivencia y la actividad antitumoral
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.El aumento de la L-arginina en las células T mejora su aptitud metabólica y supervivencia, promoviendo la actividad antitumoral. Este hallazgo revela la L-arginina
Área De La Ciencia
- Inmunología y Metabolismo
- Biología celular
Sus Antecedentes
- La actividad metabólica de las células T es crucial para su función y destino.
- Comprender los cambios metabólicos dinámicos después de la activación de las células T es clave.
Objetivo Del Estudio
- Investigar los perfiles dinámicos del metaboloma y del proteoma de las células T ingenuas humanas activadas.
- Explorar el papel del metabolismo de la L-arginina en la función y supervivencia de las células T.
Principales Métodos
- Espectrometría de masas de alta resolución para el perfil dinámico del metaboloma y del proteoma.
- Análisis de clones de células T y un modelo de ratón para validar los hallazgos.
Principales Resultados
- Se identificaron cambios significativos en el metabolismo de la arginina, disminuyendo la L-arginina intracelular.
- El aumento de la L-arginina cambió el metabolismo de las células T de la glucólisis a la fosforilación oxidativa.
- El aumento de la L-arginina promovió las células T similares a la memoria central con mayor supervivencia y actividad antitumoral.
Conclusiones
- Los niveles intracelulares de L-arginina influyen directamente en la aptitud metabólica y la capacidad de supervivencia de las células T.
- Se identificaron los reguladores transcripcionales sensibles a la L-arginina (BAZ1B, PSIP1, TSN).
- Dirigirse al metabolismo de la L-arginina representa una estrategia potencial para mejorar las respuestas de las células T antitumorales.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...